The true value of investing in cancer treatments
July 13, 2023
At Rare Cancers Australia, we believe the value of a treatment needs to look beyond the dollars on the price tag.
Read more arrow_forward
At Rare Cancers Australia, we believe the value of a treatment needs to look beyond the dollars on the price tag.
Read more arrow_forward
Rosie May Fisher can’t remember when she first noticed a pea-sized lump…
Read more arrow_forward
Opinion Piece by Richard Vines, Published in The Australian, April 2023 Did…
Read more arrow_forward
“Shocked and overwhelmed” is how Sarah McGoram describes feeling when she found…
Read more arrow_forwardGovernment funds first targeted treatment for aggressive breast cancer disproportionately affecting younger people.
Read more arrow_forward
Rare Cancers Australia (RCA) welcomes the Government’s $61.2 million funding commitment announced today for Omico’s Project, PrOSPeCT.
Read more arrow_forwardA welcome announcement this morning, 5 August 2021, from Kite, a Gilead company, and the Federal Minister for Health, the Hon. Greg Hunt, with CAR T cell therapy Yescarta now publicly funded in Australia for patients with four types of aggressive...
Read more arrow_forwardFrom the 1st May, many thousands of Australians will have better access to sophisticated, MBS-funded molecular tests to diagnose rare or less common cancers in a bid to get faster diagnoses and quicker treatment...
Read more arrow_forwardThe Hon. Greg Hunt MP, Minister for Health, announced on Tuesday the novel life-saving cancer treatment CAR-T therapy will be used for adult patients and manufactured in Australia.
Read more arrow_forward